| |
---|
| Detailed Price Information Link |
ARCHAEA | How to read the following data (Example) |
Name: | Halobacterium salinarum corrig. (Harrison and Kennedy 1922) Elazari-Volcani 1957 emend. Gruber et al. 2004 |
DSM No.: | 21899 dsm-21899 dsm21899 dsm 21899 Halobacterium salinarum |
Strain designation: | GRB-mut326-P577 |
Country: | France |
Date of sampling: | before 13.10.2008 |
Nagoya Protocol Restrictions: | France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.
To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:
1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)
2. Await approval by the Ministry for the Ecological Transition, the competent national authority
3. Respond to any requests for more information from the competent national authority
4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.
For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR
For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de |
History: | <- D. Oesterhelt, Max Planck Inst. Biochem., Martinsried, Germany; GRB-mut326-P577 <- M. Lange, Actilor, Leuna, Germany [clone P577 of mutant mut326] <- D. Oesterhelt and J. Soppa; mut326 |
Cultivation conditions: | Medium 372 , 37°C
Complete DSMZ Media List |
Summary and additional information: | <- D. Oesterhelt, Max Planck Inst. Biochem., Martinsried, Germany; GRB-mut326-P577 <- M. Lange, Actilor, Leuna, Germany [clone P577 of mutant mut326] <- D. Oesterhelt and J. Soppa; mut326. France. Taxonomy/description (9758, 21219, 21228). Organism represents a natural mutant. Isolator and source of isolation unknown. Same as DSM 670 and DSM 671. Structure of purple membrane (970, 971, 972). Bacteriorhodopsin (970, 971, 972). Sensitive to antibiotics (1604). Chemosensory responses (1607). (Medium 372, 37°C). |
Literature: | 817, 970, 971, 972, 1604, 1607, 9758, 21219, 21228 |
Risk group: | 1 (classification according to German TRBA) |
Supplied as: | Delivery form | | Prices | | Freeze Dried | | 100,- € | Active culture on request | | 240,- € | DNA | | 150,- € | | Price Category for this culture: 1 |
Freight and handling charges will be added. See price list. |
Other cultures: | All DSMZ cultures of the species |
| Print data sheet |